XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 673,906 $ 461,049
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 42,826 49,820
Deferred tax expense 1,900 4,591
Equity compensation 17,674 12,077
Loss on debt extinguishment 40,130 0
Net (gains) losses on investments and other financial instruments 8,776 (5,773)
Change in certain assets and liabilities:    
Accrued investment income (965) (3,598)
Reinsurance recoverable on loss reserves 20,521 (11,987)
Reinsurance recoverable on paid losses 36,061 143
Premium receivable (1,114) (344)
Deferred insurance policy acquisition costs 1,696 (723)
Profit commission receivable (1,497) (18,564)
Loss reserves (280,152) 52,372
Unearned premiums (33,755) (30,582)
Return premium accrual (9,200) 7,200
Current income taxes 3,140 5,453
Other, net (36,154) (8,724)
Net cash provided by (used in) operating activities 483,793 512,410
Cash flows from investing activities:    
Purchases of investments (544,224) (1,335,569)
Proceeds from sales of investments 391,394 239,483
Proceeds from maturity of fixed income securities 536,194 700,301
Additions to property and equipment (2,402) (2,388)
Net cash provided by (used in) investing activities 380,962 (398,173)
Cash flows from financing activities:    
Purchase of convertible junior subordinated debentures (88,908) 0
Redemption of 5.75% senior notes (242,296) 0
Repayment of FHLB Advance (155,000) 0
Cash portion of loss on debt extinguishment (39,445) 0
Repurchase of common stock (303,060) (150,000)
Dividends paid (81,288) (68,276)
Payment of withholding taxes related to share-based compensation net share settlement (9,958) (6,729)
Net cash provided by (used in) financing activities (919,955) (225,005)
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents (55,200) (110,768)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 304,958 296,680
Cash and cash equivalents and restricted cash and cash equivalents at end of period $ 249,758 $ 185,912